Relay Therapeutics Competitors and Similar CompaniesClear all
Relay Therapeutics's competitors and similar companies include Verastem Oncology, Walvax Biotechnology, Serum Institute of India and CSL.
 Relay Therapeutics Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities. |  Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. |  Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | |||
Founding Date | Founding Date 2016 | Founding Date 2010 | Founding Date 2001 | Founding Date 1966 | Founding Date 1916 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Needham, US HQ Walsrode, DE | Locations Kunming, CN HQ | Locations Pune, IN HQ Mumbai, IN Pune, IN | Locations Parkville, AU HQ King Of Prussia, US |
Employees | Employees 2724% decrease | Employees 7328% increase | Employees 2,388 | Employees 5,3831% increase | Employees 32,698 |
Valuation ($) | Valuation ($) 958.5 m | Valuation ($) 144.9 m | Valuation ($) 3.3 b | Valuation ($) N/A | Valuation ($) 95.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $15.4m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $15.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥615.2m (FY, 2025) | Cost of goods N/A | Cost of goods $6.5b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥1.8b (FY, 2025) | Gross profit N/A | Gross profit $9.1b (FY, 2025) |
Net income | Net income ($276.5m) (FY, 2025) | Net income ($209.5m) (FY, 2025) | Net income ¥125.2m (FY, 2025) | Net income N/A | Net income $3.1b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 520m | Total funding raised $ 170m | Total funding raised $ 72.8m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Verastem Oncology
HQ
Needham, US
Employees
73↑ 28% increase
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
View companyWalvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View company
CSL
HQ
Parkville, AU
Employees
32,698
CSL is a biotech company providing life-saving medicines.
View company